The long-term objective of this project is to gain a better understanding of mammalian muscle cell differentiation, in vivo, using mice carrying a targeted mutation at the gene encoding the myogenic regulatory protein myogenin. Myogenin is a muscle-specific transcription factor belonging to the helix-loop-helix (bHLH) class of proteins and is believed to play a crucial role in the differentiation of muscle. tissue in mammalian embryos. The role of myogenin in muscle cell differentiation will be tested directly by making use of a mouse model with a myogenin-null genotype. Using homologous recombination techniques, mice have recently been obtained that are heterozygous for the targeted mutation. The myogenin-null mice will be the starting point for a series of experiments to delineate myogenin function in vivo.
The specific aims are: (l) To characterize the phenotypes associated with myogenin-null mice, by assessing the biochemical, histological and physiological state of muscle and associated tissues in embryos, fetuses, and adults; (2) To determine the role of myogenin in regulating the expression of muscle-specific genes, including other myogenic factors and genes encoding muscle-specific structural proteins and enzymes; (3) To determine if autoregulation is required for myogenin expression, making use of pre-existing transgenic mice harboring myogenin gene control regions fused to reporter genes; (4) To determine if mice that are doubly homozygous for null mutations at the myogenin locus and other myogenic factor loci exhibit stronger phenotypes than any of the single homozygous mutations; (5) To determine if other myogenic factors or modified forms of myogenin, expressed in the same temporal and spatial fashion, can rescue the myogenin-null phenotypes; and (6) To create myogenin-null fibroblast and myoblast lines to study the potential of these cells to differentiate muscle.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR042142-02
Application #
2081316
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1993-08-01
Project End
1996-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Biochemistry
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030